Women living with a chronic disease who become pregnant will find little information about the impact of their disease on their pregnancy, or about how to manage their condition while they are pregnant. Is it safe to continue taking their medication, or should they stop? The lack of evidence-based data also leaves most physicians in the dark.
Two leading lights in women’s reproductive health (and mothers themselves), Marie Teil, Global Head, Women of Childbearing Age Program at UCB Biopharma, and Cathy Nelson-Piercy, Professor of Obstetric Medicine at Guy's and St. Thomas's NHS Foundation Trust, say that many women they’ve talked to would be willing to join research studies. And they want to educate more clinicians, pharma companies, and scientists about the need to enroll pregnant women in clinical trials.
This podcast is not available for CME/CE/CPD credits. Please visit the Medscape homepage for accredited CME/CE/CPD activities.
